Cohn, G <br/><br/>
Pathophysiology and treatment of the dyslipidemia of insulin resistance.  [electronic resource] 

 -  Current cardiology reports  Sep 2001 
 - 416-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1523-3782 
<br/><br/><label>Standard No.: </label>10.1007/s11886-001-0059-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cardiovascular Diseases--epidemiology<br/>Enzyme Inhibitors--therapeutic use<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Hyperlipidemias--physiopathology<br/>Hypoglycemic Agents--therapeutic use<br/>Hypolipidemic Agents--therapeutic use<br/>Insulin Resistance<br/>Lactones--therapeutic use<br/>Life Style<br/>Lipase--antagonists & inhibitors<br/>Metformin--therapeutic use<br/>Niacin--therapeutic use<br/>Orlistat<br/>Risk Factors